New study finds 300 mg monthly buprenorphine dose better than 100 mg for opioid abstinence, well-tolerated.
Monthly maintenance doses of 100 mg and 300 mg showed positive results in promoting opioid abstinence, being well-received with no additional safety concerns noted. Further analysis revealed that the 300-mg dose was notably more effective than the 100-mg dose in participants, indicating its superiority in the study.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments